ARCHIVES

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

This article is from The Cancer Letter archive.

Vol. 01 No. 48 | November 28, 1975

Download PDF Visit The Full Archive

Related Articles

ODAC Votes For Approval Of PegIntron For Melanoma, Votrient For Renal Cancer

October 9, 2009

RFP To Be Issued For Two More Neutron Therapy Facilities; Winners To Conduct Clinical Trials

October 27, 1978

FDA Advisors Recommend Approval Of Topotecan for Ovarian Cancer

April 26, 1996

Communication Is Key To Clinical Trial Enrollment

June 30, 2006

AACR Completes List Of Symposia Chairpersons

April 22, 1988

Neutron Therapy Contracts Wind Down Next Year; DCT To Consider Whether To Continue Support

March 25, 1988